Dr. David Cosgrove
Claim this profileNorthwest Cancer Specialists, P.C.
Studies Colorectal Cancer
Studies Lymphoma
11 reported clinical trials
28 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
MSI-H positive
dMMR positive
2Lymphoma
Affiliated Hospitals
Clinical Trials David Cosgrove is currently running
Tucatinib + Trastuzumab + Chemotherapy
for Colorectal Cancer
This study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer. This study will also determine what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the body (metastatic) and/or cannot be removed with surgery (unresectable). Participants will be assigned randomly to the tucatinib group or standard of care group. The tucatinib group will get tucatinib, trastuzumab, and mFOLFOX6. The standard of care group will get either: * mFOLFOX6 alone, * mFOLFOX6 with bevacizumab, or * mFOLFOX6 with cetuximab mFOLFOX6 is a combination of multiple drugs. All of the drugs given in this study are used to treat this type of cancer.
Recruiting2 awards Phase 3
CTX-009 + Paclitaxel
for Biliary Tract Cancer
This trial tests a new drug (CTX-009) combined with chemotherapy in patients with advanced biliary tract cancers who have already had other treatments and cannot have surgery. The treatment aims to boost the immune system and stop cancer cell growth.
Recruiting1 award Phase 2 & 36 criteria
More about David Cosgrove
Clinical Trial Related5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments David Cosgrove has experience with
- Trastuzumab
- Tucatinib
- Placebo
- Paclitaxel
- CG-806
- Brentuximab Vedotin
Breakdown of trials David Cosgrove has run
Colorectal Cancer
Lymphoma
Stomach Cancer
Esophageal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Cosgrove specialize in?
David Cosgrove focuses on Colorectal Cancer and Lymphoma. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are MSI-H positive.
Is David Cosgrove currently recruiting for clinical trials?
Yes, David Cosgrove is currently recruiting for 3 clinical trials in Vancouver Washington. If you're interested in participating, you should apply.
Are there any treatments that David Cosgrove has studied deeply?
Yes, David Cosgrove has studied treatments such as Trastuzumab, Tucatinib, Placebo.
What is the best way to schedule an appointment with David Cosgrove?
Apply for one of the trials that David Cosgrove is conducting.
What is the office address of David Cosgrove?
The office of David Cosgrove is located at: Northwest Cancer Specialists, P.C., Vancouver, Washington 98684 United States. This is the address for their practice at the Northwest Cancer Specialists, P.C..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.